Generics 10

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrronium bromide manufacturers

10 products found

Filters

10 products found

glycopyrronium bromide

Ampoules 200 μg/ml - 1 ml, 3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15084
This European pharmaceutical company specializes in the Central Nervous System (CNS) and Hospital Injectables. They operate in a niche market focusing on treatments for debilitating conditions like chronic pain and addiction. With a strong commitment to patient care, they are actively seeking new opportunities to expand their product portfolio and geographical reach, particularly within the EU market. Their core therapy areas include CNS disorders, pain management, and addiction treatment. The company has a robust research and development (R&D) program and actively seeks strategic partnerships to further its growth. This company develops and produces both prescription and over-the-counter (OTC) medications in various dosage forms, including injectables, solids, and liquids, which are manufactured under EU and other GMP standards. They hold numerous patents for their innovative drug formulations and have a track record of successful acquisitions, demonstrating their commitment to expanding their presence in the pharmaceutical industry. This company has a solid presence in the European market with an expansion into the Asia region, and is actively pursuing opportunities to expand its global footprint.

Manufacturer usually replies in 17 days

glycopyrronium bromide + indacaterol

Capsules 43 mcg + 85 mcg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 25 days

glycopyrronium bromide

Solution for injection 0,2mg/ml (1ml, 2ml)

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
New Zealand , Australia
Manufacturer #10627
NaN

Manufacturer usually replies in 7 days

Want to see all 10 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Glycopyrronium Bromide Manufacturers

Markets of interest

As an antispasmodic Glycopyrronium Bromide prescribed to treat some disorders of the gastrointestinal tract and to reduce salivation with some anesthetics. The substance is available for sale in the form of ampoules, solution for injection, capsules, from manufacturers in various countries including Y. The drug is provided by a wide range of Glycopyrronium Bromide suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Glycopyrronium Bromide manufacturers and distributors are based in China Bangladesh, and Turkey.

Licensing and brand names

In October 2015, Glycopyrronium Bromide was approved by the FDA for use as a standalone treatment for Chronic obstructive pulmonary disease (COPD) in the USA. The medication was approved by the EMA in the European Union in 2012. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Cuvposa, Enurev Breezhaler. One of the most popular branded versions of Glycopyrronium Bromide is manufactured and supplied by the Dutch pharmaceutical company Duchefa Farma B.V. Other manufacturing companies and distributors from India, Spain, Switzerland, Portugal, France, and Italy have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Glycopyrronium Bromide as an active ingredient.

Target supply price

The wholesale acquisition cost for Glycopyrronium Bromide injectable solution (0.2 mg/mL) is around $67 for a supply of 25 milliliters. The retail price of 85mcg + 43 mcg inhalable powder (hard capsules) N30 x 1 + 1 inhaler 46.45 € of the substance in Europe reaches EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Glycopyrronium Bromide manufacturers and suppliers that you are looking for. You can also find the dossier status of Glycopyrronium Bromide and the GMP approvals of the different variants of the medication. The product description of all Glycopyrronium Bromide suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Glycopyrronium Bromide is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible